0001213900-26-077974.txt : 20260714 0001213900-26-077974.hdr.sgml : 20260714 20260714163027 ACCESSION NUMBER: 0001213900-26-077974 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260714 DATE AS OF CHANGE: 20260714 EFFECTIVENESS DATE: 20260714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silo Pharma, Inc. CENTRAL INDEX KEY: 0001514183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 462137136 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590753 FILM NUMBER: 261174588 BUSINESS ADDRESS: STREET 1: 677 N. WASHINGTON BLVD CITY: SARASOTA STATE: FL ZIP: 34236 BUSINESS PHONE: (718) 400-9031 MAIL ADDRESS: STREET 1: 677 N. WASHINGTON BLVD CITY: SARASOTA STATE: FL ZIP: 34236 FORMER COMPANY: FORMER CONFORMED NAME: Uppercut Brands, Inc. DATE OF NAME CHANGE: 20190808 FORMER COMPANY: FORMER CONFORMED NAME: Point Capital, Inc. DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: Gold Swap Inc DATE OF NAME CHANGE: 20110301 D 1 primary_doc.xml X0708 D LIVE 0001514183 Silo Pharma, Inc. 677 N. WASHINGTON BOULEVARD SARASOTA FL FLORIDA 34236 (718) 400-9031 NEVADA None Uppercut Brands, Inc. Point Capital, Inc. Gold Swap Inc Corporation true Eric Weisblum 677 N. WASHINGTON BOULEVARD SARASOTA FL FLORIDA 34236 Executive Officer Director Chief Executive Officer Daniel Ryweck 677 N. WASHINGTON BOULEVARD SARASOTA FL FLORIDA 34236 Executive Officer Chief Financial Officer Wayne Linsley 677 N. WASHINGTON BOULEVARD SARASOTA FL FLORIDA 34236 Director Kevin Munoz 677 N. WASHINGTON BOULEVARD SARASOTA FL FLORIDA 34236 Director Jeff Pavell 677 N. WASHINGTON BOULEVARD SARASOTA FL FLORIDA 34236 Director Pharmaceuticals Decline to Disclose 06b false 2026-07-09 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 CA CALIFORNIA FL FLORIDA IL ILLINOIS NY NEW YORK true 4000015 4000015 0 false 4 300002 0 In connection with the offering, H.C. Wainwright & Co., LLC received $300,002 in commissions and warrants to purchase up to 46,497 shares of common stock exercisable at $8.065 per share. 0 false Silo Pharma, Inc. /s/ Eric Weisblum Eric Weisblum Chief Executive Officer 2026-07-14